Bayer wins first-in-class FDA nod for blood thinner, setting stage for BMS-J&J rival
The FDA has approved Bayer’s asundexian to slash the risk of stroke for certain patients, with the drug serving as…
The FDA has approved Bayer’s asundexian to slash the risk of stroke for certain patients, with the drug serving as…